[2026] BREDIS Healthcare Attends the Korean Society of Clinical Chemistry Spring Conference

On May 13–14, 2026, BREDIS Healthcare participated in the 2026 Spring Conference of the Korean Society of Clinical Chemistry (KSCC), held at the Gwanggaeto Hall Convention Center, Sejong University, Seoul. This marked our first meaningful encounter with the Korean Society of Clinical Chemistry. Alongside the full-scale expansion of our business into the diagnostics field, BREDIS Healthcare took the opportunity to introduce ourselves as a partner committed to growing together with the clinical chemistry field going forward. True to this year's theme, "Beyond AI, Toward AI Agents," the conference featured in-depth discussion on the adoption of AI in laboratories and the optimization of laboratory workflows. We operated a promotional booth on-site, introducing our neurology-specialized biomarker analysis services built on our ultrasensitive platforms, SIMOA and NULISA. It was truly a meaningful experience, made even more so by the many visitors who showed genuine professional interest in our precision analysis technology. We also prepared a roulette event at our booth to engage more actively with everyone who stopped by. In addition to our analysis services, we offered a lineup of BREDIS Healthcare products as prizes — including our wearable device, Chita Ring, and our health supplement line, Chita Labs — which received a great response. This gave us a wonderful opportunity to introduce our broader product lineup to many visitors in a friendly, approachable way. Following this warm first encounter with the Korean Society of Clinical Chemistry, BREDIS Healthcare will continue to stand alongside researchers in the diagnostics field, consistently bringing innovative products and services to the table. We won't forget the enthusiasm shown to us on-site, and we'll keep growing to live up to it. We look forward to your continued interest and support as BREDIS Healthcare moves forward!